leisure time -WSS

leisure time

author：focus 2025-10-01 17:34:34 - browse：2916

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

WSS

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Anthos stroke drug appears safer than common blood thinner

OTC birth control: A brief history of over the counter pill design

Gilgo Beach: Police identify another victim in serial killing investigation

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Stem cell clinics for heart failure: buyer be wary

knowledge

leisure time

knowledge

In age of alternative facts, a scholarly course on calling out crap

NYU radiologists take on the challenge of expensive MRI machines

Affirmative action in medical school literally saved lives

ER docs worry over extreme heat as a 'mass casualty event'

BioMarin wins approval for gene therapy to treat hemophilia A

CRISPR pioneers react to Casgevy, first gene

How one medical school became remarkably diverse

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

After affirmative action ruling, medical educators look to 'holistic review'

Why medical students are struggling with mental health

focus

Childhood cancer progress stalls for Black, Hispanic kids: Report

NYU radiologists take on the challenge of expensive MRI machines

The drug industry sees a key ally in the Senate prevail

2 US Navy sailors arrested for allegedly spying for China

World's first CRISPR

World's first CRISPR

leisure time

leisure time

leisure time

hotspot